- Home
- COMP vs ELAN Comparison
COMP vs ELAN Comparison
Compare COMP & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COMP
- ELAN
- Stock Information
- Founded
- COMP 2012
- ELAN 1954
- Country
- COMP United States
- ELAN United States
- Employees
- COMP N/A
- ELAN N/A
- Industry
- COMP EDP Services
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- COMP Technology
- ELAN Health Care
- Exchange
- COMP Nasdaq
- ELAN Nasdaq
- Market Cap
- COMP 4.6B
- ELAN 5.4B
- IPO Year
- COMP 2021
- ELAN 2018
- Fundamental
- Price
- COMP $9.12
- ELAN $10.42
- Analyst Decision
- COMP Buy
- ELAN Buy
- Analyst Count
- COMP 6
- ELAN 6
- Target Price
- COMP $10.92
- ELAN $15.00
- AVG Volume (30 Days)
- COMP 6.4M
- ELAN 3.8M
- Earning Date
- COMP 05-07-2025
- ELAN 05-07-2025
- Dividend Yield
- COMP N/A
- ELAN N/A
- EPS Growth
- COMP N/A
- ELAN N/A
- EPS
- COMP N/A
- ELAN 0.68
- Revenue
- COMP $5,629,100,000.00
- ELAN $4,439,000,000.00
- Revenue This Year
- COMP $26.77
- ELAN $3.20
- Revenue Next Year
- COMP $13.69
- ELAN $4.26
- P/E Ratio
- COMP N/A
- ELAN $15.12
- Revenue Growth
- COMP 15.23
- ELAN 0.50
- 52 Week Low
- COMP $3.03
- ELAN $10.03
- 52 Week High
- COMP $10.25
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- COMP 55.12
- ELAN 42.62
- Support Level
- COMP $9.17
- ELAN $10.45
- Resistance Level
- COMP $9.61
- ELAN $10.85
- Average True Range (ATR)
- COMP 0.43
- ELAN 0.36
- MACD
- COMP -0.02
- ELAN 0.03
- Stochastic Oscillator
- COMP 57.55
- ELAN 40.10
About COMP Compass Inc.
Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.